The Blood manufacturing community began implementation of Nucleic Acid Amplification Testing (NAAT) under the FDA's Investigational New Drug (IND) application process.
血液制造商开始根据FDA的研究性新药(IND)申请程序执行核酸检测(NAAT)。
The Blood manufacturing community began implementation of Nucleic Acid Amplification Testing (NAAT) under the FDA's Investigational New Drug (IND) application process.
血液制造商开始根据FDA的研究性新药(IND)申请程序执行核酸检测(NAAT)。
应用推荐